Octave Bioscience Inc
Menlo Park, US · Delaware corporation · 2 known investors
Healthtech
Founders & leadership
WH
William HagstromExecutive Officer, Director
MT
Melinda ThomasExecutive Officer
MW
Mark WeeksExecutive Officer
BB
Brook ByersDirector
TH
Thomas HawesDirector
AG
A. Grant Heidrich IIIDirector
AJ
Andrea JacksonDirector
MP
Michael PelliniDirector
GS
George ScangosDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$31.8MraisedMar 2025 · 20 investors · Other Health CareRule 506(b)
▶$31.8MraisedMar 2025 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- A. Grant Heidrich IIIDirector
- George ScangosDirector
- William HagstromDirector
- Marcel KonradExecutive Officer
- Thomas HawesDirector
- Brook ByersDirector
- Doug BiehnExecutive Officer, Director
- Lucy CoassinDirector
- Michael PelliniDirector
- Offering amount
- $53.7M
- Amount sold
- $31.8M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedNov 2023 · 2 investors · Other Health CareRule 506(b)
▶$7MraisedNov 2023 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrea JacksonDirector
- A. Grant Heidrich IIIDirector
- Thomas HawesDirector
- William HagstromExecutive Officer, Director
- Brook ByersDirector
- Michael PelliniDirector
- George ScangosDirector
- Melinda ThomasExecutive Officer
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$32.5MraisedNov 2023 · 20 investors · Other Health CareRule 506(b)
▶$32.5MraisedNov 2023 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Melinda ThomasExecutive Officer
- Brook ByersDirector
- Michael PelliniDirector
- Thomas HawesDirector
- George ScangosDirector
- A. Grant Heidrich IIIDirector
- William HagstromExecutive Officer, Director
- Andrea JacksonDirector
- Offering amount
- $37.5M
- Amount sold
- $32.5M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$32MraisedJan 2021 · 14 investors · Other Health CareRule 506(b)
▶$32MraisedJan 2021 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William HagstromExecutive Officer, Director
- Melinda ThomasExecutive Officer
- Mark WeeksExecutive Officer
- Brook ByersDirector
- Thomas HawesDirector
- A. Grant Heidrich IIIDirector
- Andrea JacksonDirector
- Michael PelliniDirector
- George ScangosDirector
- Offering amount
- $32M
- Amount sold
- $32M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedSep 2017 · 7 investors · Other Health CareRule 506(b)
▶$2.5MraisedSep 2017 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William HagstromExecutive Officer, Director
- A. Grant Heidrich IIIDirector
- Brook ByersDirector
- Melinda ThomasExecutive Officer
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.